Catalyst Wire Dossier Catalyst Wire Dossier

Edecesertib

Edecesertib · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Edecesertib, covering 2024-04-05 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) [Phase 2]

See pricing